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The past decade brought fresh insight into monocyte development and function, with the aid of 
innovative experimental models such as fate-mapping and single-cell analysis, which redefined the 
monocyte field. Monocytes in both rodents and humans are now known to consist of multiple subsets 
generated through distinct developmental pathways with diverse functional specializations. Monocyte 
fates under homeostatic conditions include the accumulation in peripheral reservoirs, the conversion 
into patrolling monocytes and the engraftment into certain resident macrophage pools. Furthermore, 
under pathological conditions monocytes can acquire effector functions such as inflammatory or 
antigen presentation activities, but can also develop regulatory properties essential for tissue repair. 
Importantly, monocytes recruited during inflammation are often functionally distinct from resident 
macrophages or conventional dendritic cells. Here we propose a historical overview of the monocyte 
field and highlight how novel concepts in monocyte heterogeneity, emergency monopoiesis and 
trained immunity are bringing exciting new perspectives to monocyte research. 
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Monocytes: not only the immature siblings of macrophages and dendritic cells.  
Monocytes make up one component of the “mononuclear phagocyte system” (MPS), which they share 
with terminally differentiated tissue macrophages and dendritic cells (DC) (Guilliams et al., 2014). 
Monocytes are defined as circulating blood cells that constitute ∼10% of peripheral leukocytes in 
humans and ∼4% of peripheral leukocytes in mice. Blood monocytes are thought to develop in the 
adult bone marrow (BM) from a dividing common myeloid progenitor (CMP) that is shared with 
erythrocytes, platelets, DC and granulocytes. Following their generation in the BM, monocytes are 
subsequently released into the peripheral circulation (van Furth et al., 1979). Historically, monocytes 
were believed to represent a bridge linking BM precursors via a circulating stage with terminally 
differentiated macrophages and DC in the tissues. Today we appreciate that in most tissues the 
majority of resident macrophages - but not all - have an embryonic origin and bypass a monocyte 
stage in the adult, while DC derive from distinct BM precursors and not from monocytes (Ginhoux 
and Guilliams, 2016; Mildner and Jung, 2014). Therefore, during the last decade, monocytes have 
freed themselves from their exclusive image as simply an immature sibling of macrophages or DC. 
Indeed, recruited monocytes during inflammation give rise to monocyte-derived cells that are 
functionally distinct from the resident macrophages and DC. Moreover, circulating monocytes can 
consist of distinct subsets that already possess functional properties before reaching the inflamed 
tissues. As such, the leading characteristic that distinguishes monocytes from other members of the 
MPS is that they are poised to be rapidly mobilized in large numbers to sites of infection or injury 
throughout the body, where they serve as particularly plastic “emergency squad” to provide pro-
inflammatory or resolving activities. These diverse effector functions can be further shaped in part by 
micro-environmental cues and spatial context.  
Monocytes lost in history  
The earliest accounts of monocytes are closely related with the introduction of the microscope in the 
mid-nineteenth century (Fig. 1). Whilst still a medical student, Paul Ehrlich was developing leukocyte 
cytological stains. By using aniline dyes in combination with neutral dyes and the nuclear morphology 
of leukocytes, he was able to compartmentalize white blood cells into mononucleated leukocytes, 
some of which he termed large mononuclears with kidney shaped nuclei or so called Übergangszelle 
(transitional cells; now known as monocytes) while others he described as polymorphonuclear cells 
with neutrophilic (neutrophils), acidophilic (eosinophils) or basophilic granules (basophils) (Ehrlich, 
1880). In 1908, Paul Ehrlich shared the Nobel Prize in Physiology or Medicine with Ilya Metchnikoff 
“in recognition of their work on immunity”. Ilya Metchnikoff was at this time establishing his theory 
of phagocytosis, giving rise to the concept of cellular innate immunity (Gordon, 2008; Metchnikoff, 
1887; Metchnikoff, 1892; Yona and Gordon, 2015). 
The term ‘monocyte’ was – to the best of our knowledge – introduced by the German physician Artur 
Pappenheim in 1910 (Pappenheim and Ferrata, 1910). Pappenheims goal at this time was to unify a 
 4 
wide variety of previously described cell types into one major subgroup – the large monocyte1. Over 
the subsequent years, the definition of monocytes became more and more stringent and was 
exclusively applied to Ehrlich’s transitional cells (Forkner, 1930; Klein, 1914; Naegeli, 1923; Sabin et 
al., 1925). Attention soon turned to the origin of monocytes and gave rise to a multitude publications 
and debates (Forkner, 1930; Naegeli, 1923; Pappenheim, 1919).  
In 1914, Awrorow and Timofejewskij conducted the first in vitro cell culture experiment of human 
leukocytes isolated from peripheral blood from a leukemic patient and concluded that lymphocytes are 
the progenitors from which macrophages arise (Awrorow and Timofejewskij, 1914). Awrorow also 
observed that these in vitro derived macrophages do not form a homogenous population, but instead 
can vary in morphology and function, depending on the culture condition and thereby foreseeing the 
plasticity of monocytes (Awrorow and Timofejewskij, 1914). The first in vivo study to observe the 
migratory behaviour of mammalian blood monocytes and differentiating into macrophages during an 
acute pathological insult was performed by Ebert and Florey (1939), using the rabbit ear chamber 
(Ebert and Florey, 1939). This rapid and substantial influx of monocyte-derived inflammatory 
macrophages at the site of inflammation led to the conclusion that the majority of inflammatory 
macrophages are derived from circulating monocytes rather than descendants of local resident 
macrophage proliferation (Leder, 1967). 
By the late 1960’s a wealth of knowledge had accumulated in relation to the monocyte and 
macrophage, leading Ralph van Furth, James Hirsch, Zanvil Cohn and colleagues to introduce the 
term MPS (van Furth et al., 1972), established on “similarities in the morphology, function, origin and 
kinetics of the phagocytes” (van Furth et al., 1972). They concluded that pro-monocytes in the BM act 
as the precursor of circulating monocytes, which can differentiate into macrophages in the tissues. It is 
important to recall that at this time, macrophages were described as either free or fixed. These fixed 
macrophages were defined, as “probably of monocyte origin, but definitive proof has not been 
obtained…the morphology and functional behaviour…justify their inclusion in the mononuclear 
phagocyte system”. The concept that fixed macrophages would be of monocyte origin was then 
incorporated as textbook knowledge and the cautionary note forgotten. Subsequent technological 
advances permitted the experimenter to examine the relationship and turnover of monocytes and 
macrophages. Tissue-resident macrophages for instance are characterized by longevity (Bouwens et al., 
1986; Melnicoff et al., 1988). Furthermore, 89Sr-induced monocytopenia in animals did not affect 
normal tissue-resident macrophage compartments and macrophage cell numbers (Naito and Takahashi, 
1991; Oghiso et al., 1988; Sawyer et al., 1982; Yamada et al., 1990). Interestingly, histological 
approaches demonstrated the first appearance of tissue colonization by fetal macrophages during 
embryonic development occurs before the establishment of definitive haematopoiesis (Mizoguchi et 
                                                
1 „Solange diese Frage noch nicht geklärt und ihre Histiogenese, Natur und Stellung strittig ist, empfiehlt es sich, 
diese Zellklasse als ‚große Monozyten’ zu bezeichnen.“ – As long as the question is not solved and their 
histogenesis, nature and position controversial remains, it is recommended to name this class of cells as ‘large 
monocytes’  
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al., 1992; Naito and Takahashi, 1991; Sorokin and Hoyt, 1992) These results suggested that at least 
some tissue-resident macrophage populations are independent of monocyte influx and show potential 
self-renewal capacity, thereby leaving the question open: what exactly are the functions of monocytes? 
 
Monocyte subsets 
Ehrlich’s transitional cell was described as a homogenous cell population with the unifying 
histological feature of a centrally located kidney shaped nucleus. However, the advent of flow 
cytometry has had an unrivalled impact on immunology by enabling the assessment of cellular 
heterogeneity. This has facilitated the identification and stratification of a number of monocyte subsets 
in a variety of species (Ziegler-Heitbrock, 2014),  including humans (Passlick et al., 1989), mice 
(Geissmann et al., 2003), rats (Ahuja et al., 1995; Barnett-Vanes et al., 2016), pigs (Sanchez et al., 
1999) and monkeys (Kim et al., 2010). Discrete populations of monocytes were first identified by 
morphology and the differential expression of the antigenic markers CD14 and CD16 in humans 
(Passlick et al., 1989; Wong et al., 2011) and represented a major milestone in monocyte biology. The 
combination of CD14 and CD16 on human HLA-DR+ cells enabled the classification of three 
principal human monocyte subsets: CD14+ CD16- monocytes, also referred to as ‘classical’ monocytes, 
make up 80-90% of the monocyte pool with the remaining 10-20% shared by CD14+ CD16+ 
intermediate and CD14Low CD16+ ‘non-classical’ monocytes. A major breakthrough in the 
characterisation of mouse monocytes arose with the generation of the CX3CR1GFP knock-in mouse 
(Jung et al., 2000), which led to the identification of two distinct CD11b+ CD115+ monocyte subsets 
with different biological functions (Geissmann et al., 2003). In mice ‘classical’ monocytes are 
characterized by the surface marker combination Ly6CHi CX3CR1int CCR2+ CD62L+ CD43Low 
(previously termed inflammatory monocytes), while ‘non-classical’ monocytes are defined as Ly6CLow 
CX3CR1Hi CCR2Low CD62L- CD43+ (Geissmann et al., 2003; Jakubzick et al., 2013; Jung et al., 2000; 
Palframan et al., 2001). Transcriptional profiling comparison between mouse and human monocytes 
correlated Ly6CHi monocytes with human ‘classical’ monocytes and Ly6CLow monocytes with their 
‘non-classical’ CD14Low CD16+ human monocyte equivalent, even though certain gene expression and 
surface marker differences exist. First, human monocytes can be identified by their HLA-DR 
expression, while only certain Ly6CHi-to-Int monocyte subsets express MHCII in mice. Furthermore, 
mouse monocytes, but not their human equivalent, are characterized by the existence of a peroxisome 
proliferator-activated receptor γ (PPARγ) signature and exhibit differences in genes involved in 
phagocytic activity (Cros et al., 2010; Ingersoll et al., 2010).  
The ratio between classical and non-classical monocytes varies between species, as in humans the 
ratio is in favour of classical monocytes while in mouse both subsets are represented equally. However, 
as we will discuss below, recent unbiased single-cell RNA sequencing studies have broadened the 
heterogeneity within the intermediate population with the identification of several distinct subsets in 
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humans (Villani et al., 2017) as well as in mice (Mildner et al., 2017). Their function and ontogeny is 
currently unclear.  
 
Development of classical monocytes 
Over a century ago Alexander Maximow postulated that haematopoiesis of distinct blood lineages 
would be a highly ordered process arising from common precursors that become progressively more 
restricted ultimately producing diverse populations of blood cells (Maximow, 1907). This tree-like 
hierarchy is modelled on the assumption of a canonical development, where a set of oligo-, bi- and 
unipotent progenitor cells become progressively more restricted and give rise through branching 
decisions to all forms of circulating blood cells (Patel and Yona, 2018)(Fig. 2a). In this model, a 
fraction of active haematopoietic stem cells (HSC (Busch et al., 2015)) have the ability to self-renew 
to generate a heterogeneous population of multipotent progenitors (MPP; (Pietras et al., 2015)) that 
further differentiate into two separate lineages, becoming either common myeloid progenitors (CMP; 
(Akashi et al., 2000)) or common lymphoid progenitors (CLP; (Kondo et al., 1997)). The CLP give 
rise to all lymphoid blood cells including T, B and natural killer cells but lack the potential to 
differentiate into the myeloerythroid lineage, while CMP have lost their lymphoid lineage capacity, 
but are instead able to differentiate into megakaryocyte/erythrocyte progenitor (MEP) and 
granulocyte/macrophage progenitors (GMP) (Akashi et al., 2000). A monocyte/DC progenitor (MDP) 
was subsequently identified within, and probably derived from, the GMP population, which was able 
to give rise to monocytes and DC but not neutrophils (Fogg et al., 2006; Olsson et al., 2016), a similar 
finding to the situation in humans (Lee et al., 2015). However, the murine MDP was also identified by 
fluorescent-activated cell sorting (FACS) within the CMP compartment and might directly emerge 
from Flt3-expressing CMP and not exclusively by GMP (Yanez et al., 2017). MDP finally make a 
binary decision to either divide into the dedicated common DC precursors (CDP) or into the unipotent 
common monocyte progenitors (cMoP). The cMoP demonstrate an exclusive development potential 
towards monocytes, since isolated and adoptively transferred cMoPs gave rise to Ly6CHi and – in a 
time delayed fashion – to Ly6CLow monocytes (Hettinger et al., 2013). cMoP have also been identified 
in human BM, where they were found amongst the GMP population (Kawamura et al., 2017). 
However, this tree-like hierarchal development is based on the isolation of FACS-purified cell 
populations using a limited set of predefined surface markers, followed by in vitro colony formation 
experiments or adoptive transfer approaches. Although these assays have been valuable to determine 
lineage potential, the genuine cell fate under physiological conditions in vivo is most likely more 
complicated. Indeed, recent advances in single-cell RNA sequencing technology has questioned the 
classical branching nature of haematopoietic differentiation and show for instance that lineage 
commitment is already evident in supposedly oligopotent progenitors (Notta et al., 2016; Perie and 
Duffy, 2016) (Fig. 2b). It was also shown that unipotent progenitors can directly emerge from HSC 
without the necessity to develop sequentially through defined intermediate bipotent precursor stages 
(Naik et al., 2013; Velten et al., 2017), which can be in part mediated by direct contact of 
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haematopoietic stem cells and lineage determining cytokines such as CSF1 (Mossadegh-Keller et al., 
2013). Unbiased single-cell RNA sequencing combined with indexed FACS-sorting of early myeloid 
precursor subsets identified cells with a monocytic transcriptional program within the CMP as well as 
GMP population (Paul et al., 2015), indicating the limitation of population analysis that is based on a 
few membrane markers. However, the insufficient depth of sequencing in single-cell RNA 
transcriptome analysis might mask other lower expressed lineage potential, which are still biological 
relevant and thereby lead to premature conclusions in respect to lineage commitment. Indeed, single 
cell liquid cultures of various precursor stages in methylcellulose colony-formation assays to measure 
the clonal outcome showed the existence of multipotent precursors cells (Tusi et al., 2018), even 
though only a limited set of cytokines were used and particular cellular-derived niche signals are 
absent in this experimental setup. Therefore it is possible that precursor populations consist of a 
mixture of multi- or at least bi-potent as well as lineage pre-committed precursor cells (indicated in 
Fig. 2b by grey and lightly coloured cells, respectively). 
The commitment towards the monocyte lineage is maintained by a distinct group of haematopoietic 
growth and transcription factors (Fig. 2a). Monocyte generation involves the transcription factors SPI1 
(encoding PU.1), IRF8, GATA2 and KLF4, since deletion of these factors strongly perturbs monocytic 
precursor composition in the BM, resulting in reduced monocyte cell numbers in the periphery (Alder 
et al., 2008; Bigley et al., 2011; Feinberg et al., 2007; Hambleton et al., 2011; Kurotaki et al., 2013; 
McKercher et al., 1996; Scott et al., 2016a; Sichien et al., 2016). However, IRF8 and KLF4 seem to 
create a regulatory circuit, since ectopic overexpression of KLF4 in Irf8-deficient cells partially 
rescues monocyte differentiation (Kurotaki et al., 2013). Furthermore, an autosomal recessive IRF8 
deficiency in humans leads to a reduced number of circulating monocytes (Hambleton et al., 2011). 
Also BACH2 has been shown to contribute as a negative regulator to monopoiesis and therefore 
Bach2-deficient mice have increased monocytes (Kurotaki et al., 2018). Importantly, the single-cell 
model (Fig. 2b) provides a different theoretical basis to study the role of transcription factors in 
haematopoiesis. A precursor may appear unaffected by a given mutation based on the restricted 
number of surface markers used for the identification of this precursor (Fig. 2a), while single-cell 
analysis may reveal that the mutation affects a pre-committed precursor within this pool of cells or 
even further upstream in the developmental tree. The MDP is for example not strongly affected by the 
loss of Irf8 (Sichien et al., 2016). However, since the MDP may contain committed monocyte- and 
cDC1-precursors it may well be that the MDP in Irf8-deficient mice only consist of cDC2- committed 
precursors and may in fact comprise of different pool of cells as compared to wild-type MDP. This 
would be overlooked in the classical analysis using a restricted set of surface markers to define the 
MDP (Fig. 2a) but will be revealed by single-cell analysis (Fig. 2b). 
Investigations into cMoP biology has uncovered that this population possess a high proliferative 
capacity (Chong et al., 2016; Hettinger et al., 2013; Kawamura et al., 2017) and are already 
characterized by Ly6C expression in mice and CD14 expression in humans, respectively (Chong et al., 
2016; Hettinger et al., 2013). Further differentiation of cMoP into mature monocytes involves a pre-
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monocyte stage, where these cells can be discriminated by the expression of the chemokine receptor 
CXCR4 (Chong et al., 2016). CXCR4+ pre-monocytes represent a transient population with further 
proliferation potential and differentiate in the BM within 24 hours into Ly6CHi CXCR4- monocytes, 
which is accompanied by up-regulation of the chemokine receptor CCR2 (Chong et al., 2016). 
Therefore, CXCR4 itself is not involved in BM egression, rather CCR2 has been shown to regulate 
BM exit of classical murine Ly6CHi monocytes (Serbina and Pamer, 2006). It was observed that 
Ly6CHi monocytes in CCR2-deficient mice become trapped within the BM, while the number of 
Ly6CHi monocytes in the periphery are dramatically reduced (Serbina and Pamer, 2006). Consequently, 
the CCR2 chemokine ligands CCL2 and CCL7, but not CCL12, are important for Ly6CHi monocyte 
egression from the BM since deficiencies in these genes leads to reduced levels of Ly6CHi monocytes 
in the circulation (Tsou et al., 2007). It has been shown that under mild inflammatory conditions 
mesenchymal stem cells and their progeny, including CXCL12-abundant reticular cells, represent the 
major source of CCL2 production in the BM (Shi and Pamer, 2011), although the situation might 
differ under healthy conditions. If CCR2 also plays a role in monocyte egression in humans is 
currently unclear. Interestingly, Ly6CHi monocyte egression from the BM also underlies a circadian 
rhythmic oscillation (Nguyen et al., 2013), which is in part CXCR4-dependent (Chong et al., 2016). 
CXCR4 also participates in the homing of classical and non-classical monocytes to central (BM) and 
peripheral (spleen) monocyte reservoirs, as the capacity of CXCR4-deficient monocytes to reach these 
organs is diminished (Chong et al., 2016).  
 
Fate of classical monocytes in healthy homeostasis 
Classical Ly6CHi monocytes represent a transient cell population with a diverse differentiation 
potential. These cells, in contrast to non-classical monocytes, are equipped with a gene-expression 
program that enables them to migrate into various tissues under homeostatic conditions. Once classical 
monocytes are released into the circulation from the BM under healthy homeostasis, they remain in 
the circulation for approximately a day, before they either traffic to repopulate a proportion of tissue-
resident macrophages in the intestine (Bain et al., 2014; Bain et al., 2013; Tamoutounour et al., 2012; 
Zigmond et al., 2012), dermis (Tamoutounour et al., 2013), heart (Epelman et al., 2014; Molawi et al., 
2014), pancreas (Calderon et al., 2015), lung (Jakubzick et al., 2013) and testis (Mossadegh-Keller et 
al., 2017), or alternatively convert into non-classical monocytes (Patel et al., 2017; Yona et al., 2013). 
However, it should be noted that the classification of tissues based on the presence or absence of adult, 
short-lived monocyte-derived macrophages is becoming increasingly complex and might vary 
according to age, gender and genetic background. For instance, while the intestine was considered as 
the prototypical example of a tissue in which macrophages are short-lived and require the continuous 
recruitment of monocytes to sustain their macrophage pool, it has recently been shown that the 
intestine also harbours a TIM4+ CD4+ macrophage population that can self-maintain for months (Shaw 
et al., 2018). 
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Therefore, under healthy physiological conditions, extravasted Ly6CHi monocytes and their monocyte-
derived descendants can be found in almost all tissues throughout the body, where they participate to a 
minor yet significant fraction of the local tissue-resident macrophage pool (Sawai et al., 2016). 
Striking exceptions of tissues in which there is little or no monocyte engraftment include the epidermis 
(Chorro et al., 2009; Merad et al., 2002), the central nervous system (Ajami et al., 2007; Ginhoux et al., 
2010; Mildner et al., 2007) and the alveolar space of the lung (Guilliams et al., 2013; Hashimoto et al., 
2013; Yona et al., 2013). These particular organs are most probably spared from adult monocyte 
infiltrates due to the combination of high self-renewal potential of theses specific tissue-resident 
macrophage populations with the restricted access to these locations for monocytes, since they are 
protected by the presence of the blood–brain and epithelial barriers. The appearance of monocyte-
derived macrophages in tissue is accompanied by the gradual replacement of embryonic macrophages 
in either a quantitative fashion close to birth (Bain et al., 2014) or gradually progressing over time 
(Molawi et al., 2014; Sawai et al., 2016; Schulz et al., 2012). Monocyte-derived macrophages show 
significant gene modifications compared to their circulating equivalent as they adapt to the local tissue 
environment, and acquire a transcriptomic signature that shows similarities to resident macrophages of 
embryonic origin, even though epigenetic, transcriptional and functional differences remain (Cronk et 
al., 2018; Lavin et al., 2014; Scott et al., 2016b; T'Jonck et al., 2018; van de Laar et al., 2016). These 
newly recruited monocyte-derived macrophages have been shown to adopt functions of tissue-resident 
macrophages that they are replacing. This has been for example elegantly demonstrated for 
melanophages of the dermis that phagocytose skin pigments. The retention of pigment cargo in the 
skin is taken-over by newly recruited monocyte-derived melanophages, which helps explains tattoo 
persistence (Baranska et al., 2018). Whether monocyte-derived resident macrophages that engraft in 
steady-state tissues always acquire a self-maintenance capacity comparable to their embryonic 
counterparts is hotly debated and seems to depend on the tissue of residence.  In contrast to this, 
monocyte-derived macrophages that engraft into the macrophage pool during inflammation show 
distinct gene signatures and often fail to self-maintain for prolonged periods of time (see below). The 
reason why monocyte-derived macrophages seed embryonic macrophage niches in particular tissues in 
steady state and how monocyte-derived cells efficiently compete with the embryonic populations 
remains largely unclear (Guilliams and Scott, 2017). It is possible that a low-grade tonic inflammation 
is required in order to recruit Ly6CHi monocytes to the tissues, since germ-free mice show 
significantly reduced numbers of monocytes and monocyte-derived macrophages in the intestine (Bain 
et al., 2014). Furthermore, continuous physical micro-trauma induced by muscle contraction like in the 
heart could hinder the survival of embryo-derived cardiac macrophages, thereby creating a niche for 
monocyte-derived cells (Molawi et al., 2014). A vacant cellular niche can also be induced 
experimentally by targeted genetic mutations or irradiation that influence the survival/proliferation of 
embryonic macrophages, while the continuously produced myeloid cells in the BM are spared of these 
effects and successfully compete with the affected embryonic derived population (Cronk et al., 2018; 
Varol et al., 2017). 
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On the other hand, current research also proposes that Ly6CHi monocytes can retain their monocyte-
like state within tissues without further differentiation into macrophages. These emigrated Ly6CHi 
monocytes act as a local monocyte reservoir and show minimal transcriptional changes (Swirski et al., 
2009) and might adopt antigen presentation functions (Jakubzick et al., 2013; Jakubzick et al., 2017), 
although their exact contribution to T cell priming in vivo and their time of residence in the tissue 
remains to be elucidated. 
An alternative maturation route for Ly6CHi monocytes, rather than leaving the circulation to develop 
into specific tissue macrophages or a local monocyte reservoir, is the transition into Ly6CLow 
monocytes within the circulation. This is associated with the establishment of de novo enhancers and 
the activation of poised enhancers that facilitate the transition into non-classical Ly6CLow monocytes 
(Mildner et al., 2017; Polletti and Natoli, 2017). Mathematical modelling of the conversion rate of 
classical monocytes to non-classical monocytes based on pulse labelling decay in comparison to the 
extravasation rate into tissues indicates that the vast majority (>90%) of classical monocytes are 
recruited to peripheral tissues where they potentially differentiate into monocyte-derived macrophages 
or enter reservoirs of undifferentiated monocytes (Patel et al., 2017; Tak et al., 2017a). Interesting 
questions arise from these data. Do tissue infiltrated Ly6CHi monocytes under physiological conditions 
sometimes convert to Ly6CLow monocytes and re-enter the circulation, or do these cells always 
differentiate into macrophages? If the latter is the case, how is the default transition program from 
Ly6CHi to Ly6CLow monocytes prevented to allow alternative macrophage development and how do 
Ly6CHi-derived macrophages transcriptionally relate to Ly6CLow monocytes? If monocytes remain as 
undifferentiated cells in specific tissue reservoirs, is there an active signal required to maintain them in 
this undifferentiated stage? Data to date indicates that infiltrating Ly6CHi monocytes show a high 
degree of differentiation potential, depending on the local tissue microenvironment, suggesting 
multiple cellular fates for tissue infiltrated Ly6CHi monocytes.  
The plastically of the Ly6CHi monocyte population ignites a number of different scenarios. It is 
conceivable that Ly6CHi monocytes may represent a heterogeneous cell population with some cells 
primed for tissue infiltration and some cells primed for the transition into Ly6CLow monocytes. 
Theoretically, the distinct circulating Ly6CHi monocyte subsets could even originate from different 
precursor cells. However, single-cell RNA sequencing of murine monocytes indicates that circulating 
Ly6CHi and Ly6CLow monocytes represent relatively homogenous populations under physiological 
conditions (Mildner et al., 2017), even though a higher sequencing depth and the analysis of a greater 
number of monocytes might uncover additional monocyte subsets. Nevertheless, the intermediate 
subsets of Ly6CInt and CD14+ CD16+ cells exhibit a certain degree of heterogeneity, in both mice and 
humans (Mildner et al., 2017; Villani et al., 2017). Specifically, murine Ly6Cint monocytes consists of 
two distinct populations, one of which is characterized by the C-type lectin receptor CD209a (DC-
SIGN) and MHCII gene family expression, while the other subset can be interpreted as the “true” 
Ly6C intermediate monocyte subset, since they represent a transcriptional landscape linking classical 
Ly6CHi cells to non-classical Ly6CLow monocytes (Mildner et al., 2017). The CD209a+ MHCII+ 
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Ly6CHi-to-int monocytes are proposed to give rise to monocyte-derived DC under pathological 
conditions (Menezes et al., 2016). The origin of these cells is currently uncertain, even though these 
cells appear to develop independently of the transcription factor C/EBPβ (Mildner et al., 2017) or 
could represent cells that re-entered the circulation following secondary lymphoid tissue infiltration 
(Jakubzick et al., 2013). As mentioned, human CD14+ CD16+ monocytes likewise show a certain 
degree of heterogeneity (Villani et al., 2017) and are characterized in general by higher HLA gene 
family expression (Gren et al., 2015; Patel and Yona, 2018; Patel et al., 2017; Schmidl et al., 2014; 
Zawada et al., 2011). However, whether the murine CD209a-expressing Ly6Cint cells have a 
homologous human equivalent remains unclear, since the newly identified human CD14+ CD16+ 
subset is characterized by a cytotoxic gene signature, while this signature was absent in the two 
murine Ly6Cint populations (Villani et al., 2017).  
Taken together, Ly6CHi monocytes represent a particularly versatile biological system that even during 
homeostasis provides various tissues, including the circulation system, with monocyte-derived cells 
that acquire incredibly diverse functions dependent on their tissue of residence. 
 
Development of non-classical monocytes 
Classical monocytes have a relatively short lifespan in the circulation of approximately one day; non-
classical monocytes display a longer lifespan of around 2 days in mice and 7 days in humans, 
respectively (Patel et al., 2017; Yona et al., 2013). This can be indirectly observed in parabiotic mice, 
in which two mice are surgically joined and share a common circulation. In this system, donor-derived 
Ly6CHi monocytes do not reach equilibrium with their host Ly6CHi monocyte counterparts, in a similar 
manner to short-lived neutrophils, while lymphocytes and Ly6CLow monocytes do (Liu et al., 2007). 
Interestingly, the lifespan of Ly6CLow monocytes can be extended to up to 2 weeks, which is likely 
dependent upon the availability of CSF1 (Yona et al., 2013), a critical factor controlling 
monocyte/macrophage maintenance (Bartocci et al., 1987; Elmore et al., 2014). Possibly due to the 
increased lifespan of Ly6CLow monocytes compared to their Ly6CHi counterparts, these cells are more 
susceptible to anti-CSF1R treatment or tamoxifen-induced deletion of the Csf1r gene. In both cases, 
the number of circulating Ly6CLow monocytes decrease, while Ly6CHi monocyte numbers remain 
unaffected (Greter et al., 2012; Hoeffel et al., 2015; MacDonald et al., 2010; Mrdjen et al., 2018). The 
flexibility in increasing the lifespan of non-classical monocytes might secure their constant cell 
numbers even under pathological conditions, when the majority of classical monocytes are recruited to 
peripheral inflammatory lesions or when their functional transition into non-classical monocytes is 
blocked, e.g. due to inflammatory stimuli. This might also explain the finding that Ccr2-deficient mice 
show approximately the same cell numbers of non-classical monocytes compared to their wild type 
counterpart, since only a minor fraction of Ly6CHi monocytes is required to replenish a long-lived 
population (Yona et al., 2013). Alternatively, Ly6CHi monocytes trapped in the BM of Ccr2-deficient 
mice may convert locally into non-classical monocytes and leave the BM in a CCR2-independent 
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manner. Interestingly, in wild type/CCR2-/- mixed BM chimeras, where half the reconstituted BM is of 
wild type origin and the other half of CCR2-/-, circulating Ly6CLow monocytes are found to have the 
same chimerism as Ly6CHi monocytes and derive mainly from wild type cells (Yona et al., 2013), 
indicating that Ly6CLow monocyte are also partially dependent on CCR2 signalling. Additional factors 
influencing Ly6CLow monocyte survival include the chemokine CX3CL1 (Landsman et al., 2009) and, 
surprisingly, TNF (Wolf et al., 2017).  
The transition of classical monocytes to non-classical monocytes has been observed with the aid of the 
ablation of circulating monocytes by clodronate-loaded liposomes, cell transfer and pulse labelling 
experiments in different species including the mouse (Sunderkotter et al., 2004; Tacke et al., 2006; 
Varol et al., 2007; Yona et al., 2013), rat (Yrlid et al., 2006), macaque (Sugimoto et al., 2015) as well 
as in humans (Patel et al., 2017) and therefore seems to present a evolutionary conserved 
developmental program. However, the identification of cellular conversion from classical to non-
classical monocytes does not exclude that some cells in the non-classical monocyte pool may develop 
without passing through a classical monocyte stage (Carlin et al., 2013). 
The mechanisms driving the conversion of Ly6CHi monocytes into Ly6CLow monocytes are now better 
understood. Delta-like 1 (Dll1) signals from endothelial cells that interact with NOTCH2 on Ly6CHi 
monocytes facilitates the conversion into Ly6CLow cells (Gamrekelashvili et al., 2016). These data 
indicate that Ly6CHi and Ly6CLow monocytes are biologically interconnected, a fact that is also 
observed on the epigenetic level, since both monocyte subsets take advantage of the same promoter 
repertoire and only show little differences in chromatin organisation (Mildner et al., 2017). The 
differences, which can be detected and arise during the Ly6CHi to Ly6CLow transition, are due to the 
establishment of de novo enhancers and activation of enhancers by histone acetylation (Mildner et al., 
2017; Thomas et al., 2016). 
On the molecular level, the conversion from classical to non-classical monocytes is accompanied by 
up-regulation of the transcription factors C/EBPβ, NR4A1 and KLF2. Absence of NR4A1 leads to 
reduced Ly6CLow monocyte survival and increased apoptosis (Hanna et al., 2011). Further epigenetic 
experiments identified one particular Nr4a1 enhancer (E2), which is specific to monocytes and the 
sole deletion of this small enhancer element leads to the absence of Ly6CLow monocytes (Thomas et al., 
2016). The transcription factors KLF2 and C/EBPβ can bind to this E2 enhancer and induce Nr4a1 
expression. Subsequently, both genes were shown to be involved in Ly6CLow monocyte generation 
(Hanna et al., 2011; Mildner et al., 2017; Tamura et al., 2017; Thomas et al., 2016). Also Csf1r is 
regulated by C/EBPβ and therefore it is likely that the absence of Ly6CLow monocytes in C/EBPβ 
deficient mice is in part due to their inefficiency to up-regulate Csf1r and Nr4a1 expression (Mildner 
et al., 2017; Tamura et al., 2017). Although it remains to be experimentally demonstrated that human 
monocytes follow a similar molecular program during transition, the transcriptional network analysis 
strongly supports C/EBPβ as a central player in human monocyte biology (Schmidl et al., 2014). 
Moreover, C/EBPβ as well as NR4A1 motif enrichment are evident in human bone marrow 
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monocytes by single-cell ATAC sequencing (Buenrostro et al., 2018; Buenrostro et al., 2017). Note 
that while single-cell RNA sequencing revealed that Ly6CLow monocytes are relatively homogenous 
population (Mildner et al., 2017), it is plausible that a distinct subset(s) of Ly6CLow patrolling 
monocytes strongly adhere to the endothelium and are not retrieved by conventional bleeding regimes. 
 
The ratio between classical and non-classical monocytes is dynamic and influenced by various signals 
with distinct outcomes on monocyte numbers and subset distribution. The proportion of circulating 
classical and non-classical monocytes varies dependent on monopoiesis, tissue infiltration or the 
emergency release of these cells from central (BM) or peripheral reservoirs. For instance, mice treated 
with the bacterial peptidoglycan muramyl dipeptide show increased conversion rate of Ly6CHi 
monocytes into Ly6CLow cells in a NOD2-dependent mechanism (Lessard et al., 2017), while low 
concentrations of Toll-like receptor (TLR) ligands in the bloodstream of mice drive CCR2-dependent 
emigration of monocytes from BM to the circulation and thereby lead to increased circulating classical 
Ly6CHi monocyte cell numbers (Shi and Pamer, 2011). In humans endotoxin induces a rapid yet 
transient monocytopenia during the first two hours after lipopolysaccharide (LPS) injection followed 
by the sequential reappearance of CD14+ CD16- classical monocytes, followed by CD14+ CD16+ 
intermediate cells and finally CD14Low CD16+ non-classical monocytes (Patel et al., 2017; Tak et al., 
2017b; Thaler et al., 2016). Also exercise and age can also influence the dynamic equilibrium of 
monocyte subsets (Heimbeck et al., 2010; Seidler et al., 2010; Verschoor et al., 2014). The number of 
non-classical monocytes is thus strongly linked to the physiological status of the organism and 
therefore represents a potential diagnostic tool during certain pathological conditions (Selimoglu-Buet 
et al., 2015). 
 
Function of non-classical monocytes in healthy homeostasis 
The function of non-classical monocytes is emerging: intravital microscopy studies have revealed that 
Ly6CLow monocytes continuously monitor the vasculature under physiological conditions through an 
LFA/ICAM-dependent crawling mechanism on the resting endothelial cells (Auffray et al., 2007; 
Carlin et al., 2013). This patrolling behaviour of Ly6CLow monocytes can be observed in capillaries, 
arterioles and venules. Similarly, human CD14Low CD16+ non-classical monocytes show patrolling 
behaviour when adoptively transferred into immuno-compromised mice (Cros et al., 2010). This 
crawling characteristic permits Ly6CLow monocytes to efficiently scavenge luminal microparticles 
under physiological conditions and they also play a key role in the surveillance of endothelial cell 
integrity.  
 
Extramedullary haematopoiesis and monocyte reservoirs 
The BM has long been established as the bona fide organ for adult monocyte generation but, 
interestingly, a fraction of murine monocyte-committed precursors, e.g. MDP and cMoP, were 
detected in the spleen under steady healthy homeostasis (Hettinger et al., 2013). Since no circulating 
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monocytic precursor could be detected in the blood (Hettinger et al., 2013), BM-independent splenic 
production of monocytes is a plausible option. The spleen serves as a significant reservoir for Ly6CHi 
as well Ly6CLow monocytes; remarkably these monocyte pools outnumber their circulating 
counterparts (Swirski et al., 2009). In addition, the lung and the skin have been proposed to harbour a 
pool of undifferentiated monocytes and might serve as reservoirs as well (Jakubzick et al., 2013). 
Under certain inflammatory circumstances, these monocytes are released into the circulation and the 
emergency extramedullary monopoiesis is augmented in an IL-1β-dependent mechanism (Leuschner 
et al., 2012). Mobilized classical monocytes from the spleen are rapidly recruited to injured tissue as 
observed in models of atherosclerosis (Robbins et al., 2012) and ischemic myocardial injury (Swirski 
et al., 2009; van der Laan et al., 2014). The precise contribution of monocytes released from peripheral 
reservoirs to the pool of monocytes recruited to inflamed tissues remain largely unknown and 
additional research is required to uncover the precise role of these monocyte reservoirs.  
 
Pathological conditions and emergency monopoiesis 
Inflammation requires the rapid recruitment of short-lived myeloid cells to sites of injury, a process 
that relies on the constant generation and mobilization of BM cells. Therefore, severe inflammation 
can induce a state of emergency that may generate monocytes with alternative antecedents to steady-
state. These include monocytes that have bypassed the canonical MDP-cMoP-monocyte 
developmental pathway and resemble neutrophil-like Ly6CHi monocytes that derive from the GMP 
((Yanez et al., 2017); Fig. 3). Another example of a recently described monocyte subset that appears 
under inflammatory conditions are the segregated nucleus-containing atypical Ly6CLow monocytes 
((SatM) (Satoh et al., 2017). SatM and neutrophil-like Ly6CHi monocytes appear to represent a 
negligible fraction of monocytes in steady-state (Mildner et al., 2017; Satoh et al., 2017; Yanez et al., 
2017), yet become conspicuous during inflammation (Satoh et al., 2017; Yanez et al., 2017). In the 
case of neutrophil-like Ly6CHi monocytes it has been proposed that LPS challenge favours GMP-
derived neutrophil-like Ly6CHi monocytes production while CpG challenge favours classical MDP-
derived monocyte production (Yanez et al., 2017). At present we lack reliable surface markers to 
distinguish neutrophil-like Ly6CHi monocytes (identified using GFI1/IRF8-reporter mice, (Yanez et al., 
2017)) from classical Ly6CHi monocytes and SatM (identified as Ly6CLow Ceacam1Hi Msr1Hi, (Satoh 
et al., 2017)) from patrolling Ly6CLow monocytes. Furthermore, mice infected with Toxoplasma gondii 
are characterized by a shift in their monocytic phenotype. These IFN-γ induced MHCIIHi Sca-1Hi 
monocytes were shown to produce more IL-10 as well as prostaglandin E2 (PGE2) and were proposed 
to be of a regulatory phenotype (Askenase et al., 2015).  
In conclusion, emergency monopoiesis does not only induce a shift in number of monocytes produced 
but also affects their function and phenotype. Because of the functional specialization of these newly 
identified monocyte subsets such as the CD209aHi MHCIIHi monocytes, the SatM and the neutrophil-
like Ly6CHi monocytes, it will be interesting to study emergency monopoiesis at the single-cell level 
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to assess whether it is associated to increased output of Ly6CHi monocytes with an altered function or 
whether it is based on the development of monocyte subsets through altered developmental pathways 
(e.g. neutrophil-like Ly6CHi monocytes or SatM), yielding cells that are not normally present in the 
steady-state and are functionally distinct from classical Ly6CHi monocytes. 
 
From emergency haematopoiesis to trained immunity 
In the recent years it has become clear that cytokines not only induce functional and phenotypical 
changes in monocytes directly but also influence the cellular outcome of haematopoietic stem cells. 
Therefore emergency haematopoiesis during infections can have long-lasting effects characterized by 
a shift in cell fate resulting in the higher production of particular immune cell types at the expense of 
other cells, such as the increased production of monocytes compared to the decreased production of 
DC (Pasquevich et al., 2015) and lymphocytes (Liu et al., 2015; Maeda et al., 2009; Pietras et al., 
2016) (Fig. 3). This can result in increased numbers and an altered activation state of monocytes even 
weeks after the pathogen clearance. This phenomenon has been termed “trained immunity” (Netea et 
al., 2016; Quintin et al., 2012). A number of cytokines have been proposed to play a key role in 
trained immunity, including IFN-γ and IL-1β, suggesting that activation of stem cells by inflammatory 
cytokines produced by immune or non-immune cells in the BM is crucial for these long-lasting 
training effects (for review see: (Boettcher and Manz, 2017)). There is however no doubt that the stem 
cells are characterized by a “trained” cellular status through epigenetic changes since haematopoietic 
stem cells isolated from animals injected with β-glucan preserved their capacity to generate more 
myeloid cells 12 weeks post transfer into untrained animals (Mitroulis et al., 2018). Similar findings 
have been reported in mice trained by Bacillus Calmette-Guérin (BCG), accompanied by the increased 
presence of myeloid biased MMP in the BM (Kaufmann et al., 2018). Trained phenotypes not only 
comprise quantitative effects on myeloid cells, but also functional aspects. Macrophages differentiated 
from BCG-trained BM cells possessed an increased capacity to kill Mycobacterium tuberculosis in 
vitro and upon intratracheal transfer in vivo. Moreover, parabiotic partners of trained animals were 
better protected against Mycobacterium tuberculosis demonstrating that circulating cells (presumably 
monocytes) and not tissue resident cells from the trained partner can mediate increased protection 
(Kaufmann et al., 2018). Trained immunity also occurs during inflammation associated with metabolic 
diseases. Ldlr-/- mice put on western high-fat diet, a standard model for atherosclerosis, develop 
systemic inflammation. When these mice were put on western diet for 4 weeks and then returned to 
control diet for additional 4 weeks, serum cytokines dropped back to steady-state levels, while BM 
and splenic myeloid cells produced more inflammatory cytokines upon TLR stimulation compared to 
control mice (Christ et al., 2018).  
The concept of trained immunity has been translated to humans. BCG vaccination induced epigenetic 
changes in circulating monocytes of healthy volunteers 4 weeks after vaccination (Arts et al., 2018). 
BCG-vaccinated individuals displayed lower circulating viral titters upon subsequent experimental 
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viral infection and their PBMCs produced higher levels of IL-1β, TNF and IL-6 upon stimulation in 
vitro. Importantly, no transcriptomic changes were observed in monocytes in these subjects, 
highlighting the need to study epigenetic modifications when examining trained immunity. 
Taken together, these studies demonstrate that inflammation-induced emergency haematopoiesis – 
with IL-1β and IFNs emerging as the main drivers – can result in trained immunity characterized by 
long term epigenetic effects on stem cells to generate higher quantities of monocytes possessing 
increased reactivity to various TLR stimulations and superior killing activities against pathogens. The 
epigenetic changes associated with monocyte training involve histone modifications of genes encoding 
pro-inflammatory cytokines such as IL-6 and TNF but also of genes involved in the mTOR pathway 
(Netea et al., 2016; Quintin et al., 2012). Changes in the mTOR metabolic pathway seem essential for 
monocyte training since inhibition of mTOR reduced the increased TNF production associated with 
training (Cheng et al., 2014). 
The particular factors involved in the epigenetic modification of stem cells and whether training of 
stem cells is also associated with an increased production of particular subsets of monocytes is 
currently unknown (Fig. 3). It will also be important to experimentally demonstrate the intrinsic effect 
of training on the function of monocyte-derived cells. Indeed, in many training experiments it is 
difficult to distinguish between the indirect effects of prior inflammatory reactions (effect on local 
stromal cells, resident macrophages or memory lymphocytes) from the direct effect on BM stem cells 
and their trained monocyte progeny. 
 
Function of classical monocytes during pathology 
Under pathological conditions monocytes gain distinct non-redundant functions that often cannot be 
fulfilled by resident macrophages and DC. These non-exclusive and sometimes overlapping effector 
functions comprise pro-inflammatory activities, antigen presentation (monocyte-derived DCs) and 
tissue remodelling / anti-inflammatory abilities  (Fig. 4).  
 
The contribution of monocytes during inflammation  
The function and importance of pro-inflammatory monocytes is well documented in autoimmune 
diseases, such as the animal model of multiple sclerosis, experimental autoimmune encephalomyelitis 
(EAE), rheumatoid arthritis, colitis and bacterial infections (Udalova et al., 2016). During these 
diseases, Ly6CHi monocytes are mobilised from the circulation or peripheral reservoirs, resulting in 
the rapid influx of classical monocytes into the affected tissue or organ. Initial experiments with 
CCR2-deficient mice that lack most circulating classical monocytes showed that these mice are 
virtually resistant to EAE induction (Fife et al., 2000; Izikson et al., 2002), a phenotype that could be 
later attributed to reduced numbers of pro-inflammatory monocytes in this mouse strain and to the 
pathogenic function of monocytes during disease development (Ajami et al., 2011; King et al., 2009; 
Mildner et al., 2009). It was also shown that while infiltrated monocytes show an inflammatory 
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phenotype in EAE, tissue resident microglia on the other hand were phagocytotic active and did not 
show an overt pro-inflammatory gene signature (Yamasaki et al., 2014), indicating a division of labour 
between these myeloid subsets.  
Even though EAE is considered to be a T cell-mediated disease, all attempts to identify classical 
effector T cell-secreted cytokines with encephalogenic activities like IFN-γ, IL-17, IL-22 and IL-12 
failed (reviewed in (Becher and Segal, 2011)). However, mice lacking Csf2, which is secreted in a 
RORγt-dependent manner by CD4+ T cells (Codarri et al., 2011), are completely protected to EAE 
induction (McQualter et al., 2001). Even though CSF2 is not directly involved in monocyte generation 
(Hibbs et al., 2007), CSF2 can determine the functional outcome of monocyte-derived cells under 
pathological conditions. Using CCR2-CreERT2 mice it was demonstrated that CSF2R-signaling is 
needed for the production of inflammatory cytokines and chemokines by monocyte-derived cells in 
EAE (Croxford et al., 2015). Furthermore, the sole overexpression of CSF2 by T cells renders 
monocytes towards an MHCII+ CD11c+ phenotype and leads to CNS infiltration and CNS tissue 
damage in an antigen-independent manner (Spath et al., 2017). A comparable CNS pathology could 
also be observed in mice receiving peripheral FLT3L injection in combination with the transgenic 
overexpression of CCL2 in oligodendrocytes, which was also T cell independent (Furtado et al., 2006). 
Since FLT3L injection also increases the number of circulating monocytes (Furtado et al., 2006; 
Mrdjen et al., 2018), the observed phenotype in these mice might be in part similarly mediated by 
pathogenic monocytes.  
Similar to the situation in EAE, Ccr2-deficient mice are protected in dextran sulphate sodium (DSS)-
induced colitis, a model of ulcerative colitis (Platt et al., 2010), which indicates a similar detrimental 
role for monocyte-derived effector cells (Zigmond et al., 2012). However, colitis does not rely on 
CSF2 signalling since Csf2-deficient mice are more susceptible to DSS-induced colitis (Xu et al., 
2008), while CSF2 administration ameliorates clinical symptoms and accelerates colonic tissue repair 
(Bernasconi et al., 2010). These data are in accordance with the observation that T cell-restricted 
overexpression of CSF2 does not lead to any monocytic infiltration in the intestine (Spath et al., 2017). 
Effector monocytes recruited during DSS-colitis, produced less IL-10 and more TNF than resident 
monocyte-derived macrophages that developed before the onset of colitis (Bain et al., 2013). This lack 
of IL-10 production may further drive colitis although it is the IL-10 produced by regulatory T cells, 
but not resident monocyte-derived macrophages that is crucial to maintain homeostasis in the colon. 
One of the main functions of intestinal IL-10 is to suppress monocyte-derived cells themselves as lack 
of IL-10R on intestinal myeloid cells leads to spontaneous colitis (Zigmond et al., 2014a). 
Another subset of effector monocytes are the TNF/iNOS-producing (Tip)-DC, which were originally 
identified in the spleen of mice during Listeria monocytogenes infection (Serbina et al., 2003), but 
could also detected in mice infected with the parasite Trypanosoma brucei (Bosschaerts et al., 2010; 
Guilliams et al., 2009), Toxoplasma gondii (Dunay et al., 2008) or Leishmania major (De Trez et al., 
2009). TipDCs derive from Ly6CHi monocytes (Guilliams et al., 2009; Serbina et al., 2003) and are 
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characterized by the surface marker expression CD11cInt MHCII+ Ly6CInt and by their high production 
of TNF and nitric oxide. Although these cells were classified as “DC” due to their considerable CD11c 
and MHCII expression, their contribution to CD4+ T cell priming during Listeria infection appears 
negligible (Serbina et al., 2003). The term TipDC is therefore misleading and should be avoided in our 
view. Rather these cells excel in the killing of pathogens as demonstrated by the much higher Listeria, 
Toxoplasma and Leishmania burden in mice lacking recruited monocytes (De Trez et al., 2009; Dunay 
et al., 2008; Serbina et al., 2003), highlighting that the resident macrophage pool is not sufficient to 
clear these pathogens and require assistance from recruited effector monocytes. Note that the 
accumulation of effector monocytes during infections can also significantly contribute to collateral 
tissue damage (Guilliams et al., 2009). 
It was recently reported that effector monocytes actively participate in the development of fibrosis. 
This involves the specific subset of GMP-derived C/EBPβ-dependent SatM that produce high levels of 
TNF. Mice lacking C/EBPβ  were protected from bleomycin-induced fibrosis and the transfer of wild 
type SatM was sufficient to restore fibrosis development (Satoh et al., 2017). Monocytes also 
differentiate into pathogenic foam cells in the atherosclerotic plaques (Hilgendorf et al., 2015). 
Anitschkow (Dock, 1958) demonstrated that by feeding rabbits purified cholesterol caused vascular 
changes leading to the formation of lesions and the presence of cholesterol-laden cells (foam cells) 
similar to those detected during atherosclerosis in humans. Now we know that foam cell in the 
atheroma are descendants of selectively recruitment classical monocytes. These monocytes 
accumulate in the growing lesions, take-up excess lipid particles and further exacerbate the disease by 
producing inflammatory cytokines and chemokines that attract additional monocytes. CCR5 and 
CX3CR1 appear to be involved in their retention within the atherosclerotic plaque (Tacke et al., 2007) 
and it was demonstrated that foam cells also proliferate extensively within the plaque (Robbins et al., 
2013).  
These examples highlight how recruited monocytes play an essential role as an emergency squad, 
acquiring strong microbicidal and pro-inflammatory activity. Monocytes are therefore not simply 
precursors that get recruited to temporarily increase the number of resident macrophages. Monocyte-
derived macrophage recruited in inflamed tissues are in fact functionally distinct from the resident 
macrophages and are crucial for host defence, but at the same time can significantly exacerbate 
clinical symptoms by inducing collateral tissue damage. Nevertheless, in certain situations, such as 
helminth infections, IL-4 can drive the proliferation and the immune response of resident macrophages 
without the aid of recruited monocytes (Jenkins et al., 2011). 
 
Monocytes and antigen presentation 
Monocytes can acquire antigen-presentation capacities and display a DC-like phenotype. This was 
initially observed when human blood myeloid cells were stimulated with CSF2 alone or in 
combination with IL-4, which promotes the differentiation into CD11c+ MHCII+ CD11b+ cells with 
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soluble antigen presenting capacity in vitro (Sallusto and Lanzavecchia, 1994). These monocyte-
derived DC could be obtained by culturing murine BM cells with CSF2 (Inaba et al., 1992). However, 
it was recently shown that CSF2-treated BM cultures consist of a heterogeneous cell population 
developing from distinct precursors, including conventional DC precursors (Helft et al., 2015). 
Therefore, in order to evaluate the antigen-presentation capacity of monocyte in vitro, it is advisable to 
FACS sort pure monocytes as a starting population. Mouse monocytes cultured in presence of IL-4 
and CSF2 were shown to cross-present cell-associated antigen efficiently (Briseno et al., 2016). These 
monocyte-derived DC expressed high levels of BATF3 and IRF4. Interestingly, Batf-triple deficient 
cells, but not Irf4-deficient cells, still cross-presented antigen thereby demonstrating that cross-
presentation is controlled by distinct transcriptional programs in monocyte-derived DC as compared to 
Batf-dependent cDC1, which do not require IRF4 for this function. IRF4 was also reported to be 
essential for the IL-4 driven development of monocyte-derived DC from human monocytes in vitro 
(Goudot et al., 2017). Comparable to the situation in mice, high-dimensional mass cytometry analysis 
revealed that in vitro cultures of human monocytes with CSF2 and IL-4 yield cells with important 
phenotypic heterogeneity (Sander et al., 2017). This could potentially be the result of different human 
monocyte subsets that are present in the circulation (see above). Indeed in mouse it was found that a 
small subset of CD209a+ monocytes possess a greater potential to differentiate into monocyte-derived 
DC (Menezes et al., 2016). It is possible that this population is boosted by CSF2 treatment.  
It has been challenging to assess the contribution of monocyte-derived DC to antigen-presentation in 
vivo. For an overview of the studies proposing a role of monocyte-derived DC in antigen-presentation 
we redirect the reader to a recent review on the subject (Jakubzick et al., 2017). Multiple studies have 
demonstrated that monocytes can take up, process and present antigen in vivo but whether this 
contribution is significant to T cell priming compared to antigen-presentation by classical DC is 
debatable and seems to depend on the inflammatory context. Unfortunately, it has not been possible to 
restrict antigen-presentation to monocyte-derived DC or to specifically knock-down antigen-
presentation in these cells in vivo. Moreover, we still lack reliable in vivo markers to distinguish 
activated cDC2 from monocyte-derived DC and, finally, it is not clear whether in vivo monocyte-
derived DC differentiate solely from CD209a+ monocytes or whether multiple monocyte subsets have 
the ability to acquire a monocyte-derived DC profile in tissues.  
 
Contribution of monocytes during tissue remodelling   
Inflammation is fundamental to the survival of an organism, as it ensures defence against harmful 
external stimuli but also repair to injured tissue. The resolution phase of the inflammatory response is 
not a passive process – the objective of this phase is to re-establish the tissue back to healthy 
homeostasis (Hunter, 1794) and if this resolution phase is disrupted, chronic inflammatory diseases 
can occur. Mononuclear phagocytes help orchestrate a number of aspects of the resolution phase: for 
example, the safe disposal of cell debris, cytokine catabolism and the release of regulatory cytokines 
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and eicosanoids (Newson et al., 2014). Monocytes can already acquire a regulatory phenotype before 
reaching the injured or infected tissue whist still in the circulation (Askenase et al., 2015).  
In a model of resolving myocardial infraction, CCR2-expressing infiltrating monocytes are thought to 
promote tissue remodelling and repair via expression of VEGF that induces angiogenesis and by 
promoting myofibroblast accumulation (Nahrendorf et al., 2007), and this reparative behaviour is 
dependent on NR4A1 (Hilgendorf et al., 2014). In paracetamol-induced liver injury infiltrating 
monocytes are essential for hepatic regeneration and clearance of neutrophils (Graubardt et al., 2017; 
Zigmond et al., 2014b). This anti-inflammatory phenotype was also adopted during CCl4-induced liver 
fibrosis, where infiltrating Ly6CHi monocytes recruited to the fibrotic liver are responsible for the 
resolution of tissue fibrosis by degrading extracellular matrix, clearing cell debris and accelerating 
scar resolution (Ramachandran et al., 2012). Ly6CHi monocytes are also recruited to chronic allergic 
inflammed skin, where they differentiate in the presence of basophils and in an IL-4-dependent 
mechanism into an anti-inflammatory cell to dampen the allergic response (Egawa et al., 2013). In this 
context is was also shown that IL-4-activated monocyte-derived F4/80int CD206+ macrophages 
undergo in the presence of vitamin A a conversion into macrophages with a tissue-resident F4/80hi 
CD206- phenotype in the peritoneal cavity of mice (Gundra et al., 2017). A similar mechanism was 
also observed during the formation of liver granulomas in mice infected with Schistosoma mansoni 
(Gundra et al., 2017). Monocytes recruited to the retina injury play an essential role in the survival and 
proliferation of retinal progenitor cells by the production of high levels of IL-10 (London et al., 2011). 
In a model of spinal cord recovery following the centralised injury of the spinal cord, recruited Ly6CHi 
monocyte adopt an anti-inflammatory phenotype and secret IL-10, possibly counteracting the 
detrimental activity of resident microglia (Shechter et al., 2009). This highlights the regulatory role 
monocyte possess, which can dampen the activation of resident macrophages. Finally, development of 
monocyte-derived macrophages with a tissue remodelling phenotype following injury is not always 
binary (with monocytes differentiating in either pro- or anti-inflammatory macrophages). For instance, 
injection of the tiger snake venom notexin, a myotoxin phospholipase leads to the destruction of 
skeletal muscle, is accompanied by the infiltration of Ly6CHi monocytes that first display an early pro-
inflammatory phenotype, before converting into a reparative monocyte-derived macrophage with the 
capacity to stimulate myogensis, fibre growth and restore muscle integrity (Arnold et al., 2007). Taken 
together, these studies highlight the plasticity of monocytes and demonstrate that these cells are 
essential for tissue repair and perform tasks that are not efficiently performed by resident macrophages. 
 
Role of monocytes in cancer   
Mononuclear phagocytes are located in both healthy and pathological tissue. The tumour 
microenvironment is no exception and the contribution of monocytes to tumour development is a 
multifaceted process ranging from the initiation of vessel growth to immune escape and metastasis. 
Tumours circumvent recognition and cell mediated elimination by suppressing the anti-tumor immune 
response. In this regard, it was shown that tumours affect myelopoiesis in the BM and induce the 
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expansion of myeloid cells with immunosuppressive activity, in both animal models and human 
patients (Bronte et al., 2016). These cells were originally characterized by CD11b and Gr1 expression 
and termed myeloid-derived suppressor cells’ (MDSC). However, CD11b and Gr1 (which recognizes 
both Ly6C and Ly6G) define classical monocytes as well as neutrophils and therefore both myeloid 
cell populations could potentially contribute to T cell suppression. Analysis of this CD11b+ Gr1+ 
subset as a homogenous population has caused conflicting results and confusion concerning the nature, 
function and ontogeny of these cells. The addition of further cell surface markers unmasked the 
presence of monocytic and polymorphonuclear MDSC and allowed the independent analysis of both 
subsets (Bronte et al., 2016; Gallina et al., 2006; Huang et al., 2006; Movahedi et al., 2008). 
Subsequent adoptive transfer experiments and molecular analysis identified that monocytic MDSC are 
derive from circulating Ly6CHi monocytes, either directly from the BM or from the splenic peripheral 
reservoir in a CCR2-dependent manner (Cortez-Retamozo et al., 2012; Shand et al., 2014). The 
presence of hypoxic conditions, high concentrations of oxidative agents, the release of pro-
inflammatory cytokines, and limited supply of nutrients makes the tumour environment a relatively 
harsh milieu. Monocytes, which infiltrate the tumour tissue under these circumstances, might 
consequently acquire a pro-inflammatory signature that dampens lymphocyte activities, survival and 
proliferation in general – a phenomenon reflected in the suppressive activities of MDSC. However, 
these infiltrating Ly6CHi monocytes can further differentiate into tumour-associated macrophages 
(TAM), which are – similar to the situation in other pathological contexts – characterized by low 
Ly6C expression and differential expression of MHCII, CD11c and CX3CR1 (Movahedi et al., 2010). 
In general, TAM represent the majority of tissue-resident macrophages in tumours beside a small 
fraction of embryonic-derived macrophages (Franklin et al., 2014) but a differential role for 
embryonic macrophages have also been proposed  
(Bowman et al., 2016; Zhu et al., 2017). TAM provide maintenance activities for tumour growth by 
facilitating angiogenesis, acting as pathfinders for endothelial cells, which provide oxygenation and 
nutrients to the growing tumour, as well as by clearing waste products. TAM exhibit negative 
activities on T cells and express high levels of programmed death ligand 1 (PD-L1), a ligand for 
immune-checkpoint receptor that restricts CD8 T cell activities (Noy and Pollard, 2014). Monocyte-
derived TAM therefore represents an essential component of the developing tumours by critically 
contributing to survival, protection and growth of tumour cells. The development of monocytic MDSC 
and TAM is dependent on the transcription factors IRF8 (Waight et al., 2013), STAT3 (Chalmin et al., 
2010), RBPJ (Franklin et al., 2014) and CEBP/b (Marigo et al., 2010).  
Finally, the majority of deaths from solid tumours are a result of metastasis. Monocytes promote 
metastasis by preparing the potential microenvironment and enable the dissemination of metastatic 
cells (Keirsse et al., 2018). Classical monocytes are recruited to the metastatic site in a CCL2-CCR2 
dependent fashion and, once embedded within this niche, these recruited monocyte-derived cells 
promote the survival and growth of the metastatic tumour (Qian et al., 2011).  
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In conclusion, whilst it is clear that monocyte-derived cells play an important role in cancer, many 
confusing and out-dated concepts (like the MDSC and M1 versus M2 tumor associated macrophages) 
have been plaguing the cancer literature. In the end, tumour mononuclear phagocyte biology should be 
analysed like any other pathological tissue with the potential of diverse roles for resident macrophages 
versus recruited monocytes, with the possible existence of particular pre-committed monocyte subsets 
with specific functional specialization, and with the potential existence of distinct micro-environments 
or “niches”. The advance of fate mapping tools, single-cell sequencing, spatial transcriptomics and 
multiplexed microscopy will surely shed light on the precise role for monocytes in cancer and will 
hopefully yield novel anti-cancer strategies. 
 
Function of non-classical monocytes during pathology 
The function of Ly6CLow monocytes during inflammation remains controversial. The existence of 
Ly6CHi and Ly6CLow monocytes within the injury site was originally interpreted as evidence that both 
classical and non-classical monocytes can infiltrate the tissue in a sequential manner and might 
contribute distinct pro- and anti-inflammatory activities. Alternatively, infiltrated Ly6CHi monocytes 
can lose their Ly6C expression while increasing F4/80, CD11c and CX3CR1 expression during the 
differentiation process into effector monocyte-derived cells in the tissue, making them 
indistinguishable from circulating Ly6CLow monocytes (Arnold et al., 2007; Avraham-Davidi et al., 
2013; Zigmond et al., 2012). Examining the phenotype of infiltrating cells at the site of injury and 
extrapolating their origin based on surface markers has therefore caused much confusion.  
Further insight into the nature of non-classical monocytes came from the observation that Nr4a1-
deficient mice are characterized by a strong reduction of circulating Ly6CLow monocytes (Hanna et al., 
2011). Therefore, this mouse model in combination with the CX3CR1gfp reporter mouse (Jung et al., 
2000) has become a useful tool to study the functional role of Ly6CLow monocytes during different 
pathological conditions. It was shown that these patrolling Ly6CLow monocytes interact with metastatic 
tumour cells, scavenge tumour material from the lung vasculature, and initiate natural killer cell 
recruitment and activation (Hanna et al., 2015; Plebanek et al., 2017). Ly6CLow monocytes are also 
able to target and eliminate amyloid-β within the lumen of veins and the absence of these cells due to 
Nr4a1-deficiency increased amyloid-β deposits within the cortex and hippocampus of mice (Michaud 
et al., 2013). 
As a word of caution, Ly6CHi monocyte function is not completely independent of the transcription 
factor NR4A1, since Ly6CHi monocytes that infiltrate the infarcted myocardium show increased 
expression of NR4A1(Hilgendorf et al., 2014). Furthermore, up-regulation of this transcription factor 
was accompanied by reduced pro-inflammatory activities and a reparative phenotype, while absence 
of NR4A1 led to a more inflammatory phenotype in Ly6CHi monocyte derived cells, which results in 
defective healing and compromised heart function (Hilgendorf et al., 2014). Similar results were 
obtained in an animal model of atherosclerosis, in which Nr4a1-deficient monocytes and macrophages 
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displayed enhanced toll-like receptor signalling and a polarization towards a pro-inflammatory 
phenotype (Hanna et al., 2012). Therefore, it is difficult to interpret the phenotype observed in Nr4a1-
deficient mice as being exclusively due the absence of Ly6CLow monocytes. A new and elegant mouse 
model will help to resolve these uncertainties. Deletion of a monocyte-specific Nr4a1-enhancer 
element (E2) resulted in the loss of peripheral non-classical monocytes, while NR4A1-dependent 
inflammatory pathways were preserved in macrophages (Thomas et al., 2016).  
Beside these complications in deciphering results from mice with an absence of Ly6CLow monocytes, 
some specific functions during inflammation have been attributed to these cells. Following exposure 
to TLR7-mediated 'danger' signals, mimicking viral infection or local cell death, a CX3CR1-dependent 
retention of Ly6CLow monocytes on the affected endothelium was observed (Carlin et al., 2013). The 
TLR7 ligand triggered monocytes lead to the recruitment of neutrophils, which mediated focal 
endothelial necrosis, while subsequently Ly6CLow monocytes remove cellular debris (Carlin et al., 
2013). Recently it was shown that non-classical monocytes are superior producers of TNF following 
poly(I:C) injection (Garre et al., 2017). The secretion of TNF by these cells led to reduced learning-
induced dendritic spine remodelling in pyramidal neurons and consequently to deficits in learning 
behaviour (Garre et al., 2017). The production of TNF in response to viruses was also shown for 
human non-classical monocytes (Cros et al., 2010) and it is possible that future research will indicate a 
specialisation of Ly6CLow monocytes in anti-viral immunity. Finally, recently it was proposed that 
Ly6CLow monocytes exhibit a protective effect during the early stages of atherogenesis by maintaining 
endothelial cell integrity (Quintar et al., 2017). 
 
Engraftment of monocytes in the resident macrophage pool during pathology 
Another way by which inflammation-induced monocytes possessing an altered activation state will 
exert long-lasting effects on tissues is by integrating into the resident macrophage pool (Bonnardel and 
Guilliams, 2018). In some disease models, but not in others, the macrophage disappearance reaction 
that is often associated with inflammation (Barth et al., 1995) results in the engraftment of monocytes 
in the resident macrophage niche (Guilliams and Scott, 2017). In the case of the liver as an example, 
experimental diphtheria toxin induced depletion (Scott et al., 2016b), Listeria monocytogenes 
infection (Bleriot et al., 2015), non-alcoholic steatohepatitis (Devisscher et al., 2017), overload of 
senescent red-blood cells (Theurl et al., 2016), chemical induced liver fibrosis (Ramachandran et al., 
2012) and paracetamol induced liver-injury (Zigmond et al., 2014b) result in partial Kupffer cell loss. 
Subsequently, infiltrating monocytes can differentiate into Kupffer cells during all these experimental 
models apart from paracetamol-induced liver injury, which solely relies on the proliferation of the 
remaining Kupffer cells to refill this niche (Zigmond et al., 2014b). A recent report demonstrates that 
monocyte to Kupffer cell differentiation is suppressed by Type I IFN signalling during a model for 
viral hepatitis (Borst et al., 2017). The underlying mechanism is unclear. Is Type I IFN inducing the 
generation of BM inflammatory monocytes that are blocked from becoming Kupffer cells before 
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reaching the liver? Does Type I IFN change the local microenvironment in the liver and block 
monocyte to Kupffer cell development?  
When monocytes enter the Kupffer cell pool during inflammation it is uncertain whether these cells 
are functionally distinct from embryonic Kupffer cells. Indeed, it may be that these cells have been 
trained by the inflammation present during their development and are therefore more reactive to 
subsequent stimuli. In some models these monocyte-derived Kupffer cells eventually disappear from 
the Kupffer cell pool (Devisscher et al., 2017; Theurl et al., 2016), suggesting a diminished self-
maintenance capacity compared to embryonic Kupffer cells.  
Gammaherpes virus infection has been associated with the generation of IL-10 producing MHCIIHi 
Sca-1Hi monocytes within the BM (Machiels et al., 2017). These monocytes resemble monocytes with 
a regulatory phenotype produced during Toxoplasma gondii infection (Askenase et al., 2015). 
Interestingly, gammaherpes virus infection also resulted in the engraftment of these regulatory 
monocytes in the alveolar macrophage pool. These virus-induced monocyte-derived alveolar 
macrophages did not only self-maintain for months but retained an altered activation state that 
protected against the development of allergic asthma. Lung fibrosis was also associated with the 
differentiation of monocytes into self-maintaining alveolar macrophages with an altered gene-
expression profile (Misharin et al., 2017). Whether the altered activation state of monocyte-derived 
alveolar macrophages in these models is imprinted locally by the virus infected or fibrotic lung or is in 
part determined by emergency monopoiesis in the BM is currently unknown. Moreover, whether these 
models of inflammation result in the production of a particular subset of monocytes possessing the 
unique capacity to self-maintain or to generate functionally distinct alveolar macrophages remains to 
be determined. Finally, it will be interesting to understand the epigenetic modifications of resident 
macrophages that were present prior to the inflammatory insult and that may also have undergone 
inflammatory training or tolerance. Is the long-term imprinting in the resident macrophages that were 
present before the inflammation comparable to the long-term imprinting in macrophages that derive 
from monocytes differentiating during the inflammation (Bonnardel and Guilliams, 2018)? 
These examples demonstrate that monocytes can integrate into resident macrophage pools during 
inflammation, but whether these cells can self-maintain for prolonged periods appears to depend on 
the tissue and the inflammatory context. New fate mapping systems that faithfully label the monocyte-
derived macrophages that engraft during inflammation will be required to assess their contribution to 
the local immune responses. 
 
 
Conclusion and future directions 
 
It is becoming clear that the substantial recruitment of monocytes to inflamed tissues does not merely 
function to temporarily increase the number of resident macrophages and DC. Instead, these 
infiltrating monocytes will often perform functions that cannot be performed by resident macrophages 
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or DC and will acquire very distinct functional profiles depending on the tissue and the inflammatory 
context. These monocytic phenotypes include effector monocytes with inflammatory, antigen 
presentation, regulatory or resident macrophage profile, although these phenotypes can overlap. 
Recently new monocyte subsets have been described under inflammatory as well as healthy conditions 
such as the neutrophil-like Ly6CHi monocytes, the SatM or the CD209+ monocytes. These cells have 
been proposed to display increased pro-inflammatory, pro-fibrotic and antigen-presentation capacities 
as compared to steady-state Ly6CHi monocytes. The identification of these cells highlights that single-
cell analysis will profoundly reshape the monocyte field and may reveal the presence of monocytes 
primed for specific functions in many models. Future examination will be required to assess whether 
these monocytes indeed remain functionally distinct as compare to classical Ly6CHi that get recruited 
to the same inflamed tissue, since the local inflammatory cues may over-write the differences found in 
the circulating monocytes. 
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Figure 1: Historical leukocyte identification. By 1908, blood leukocytes could be stratified on the 
basis of their morphology and their staining properties. Different staining techniques are depicted here 
with 1. Lymphocyten: lymphocyte 2. Grosse mononukleäre Zellen: Great mononuclear cell 3. 
Übergangsformen: Ehrlich’s transitional cell (monocytes) 4. Neutrophile: neutrophil 5. Eosinophile: 




Figure. 2: Development of murine monocytes under physiological conditions. A. Depiction of the 
classic hierarchical representation of haematopoietic development in the bone marrow. Oligopotent 
precursors such as haematopoietic stem cells (HSC) or multipotent precursors (MPP) become 
progressively more restricted and give rise through intermediate precursor stages to all forms of 
circulating blood cells. In this view, defined multipotent precursor populations such as granulocyte 
macrophage precursors (GMP) produce either the granulocytic lineage or further differentiate into 
monocyte-macrophage/dendritic cell precursors (MDP). Bipotent MDPs further make binary decisions 
and either give rise to common dendritic cell precursors (CDP) or to common monocyte precursors 
(cMoP). cMoP finally differentiate into Ly6CHi cells, which are released into the circulation and can 
acquire different cell fates, including the transition into Ly6CLow monocytes patrolling blood vessels or 
monocyte-derived macrophages in tissues. The main transcription factors involved in monocyte 
development are shown. CLP: common lymphocyte precursors. CMP: common myeloid precursors. 
MEP: megakaryocyte/erythrocyte progenitors. B. Development of the haematopoietic system based on 
single-cell analysis. In this view, haematopoietic development starts with few active HSC, which fill a 
pool of MPPs. Subsets of MPPs exist (indicated by the numbers 2-4 according to (Pietras et al., 2015)) 
that are already primed towards certain cell lineages or even show a cellular identity comparable (but 
not identical) to terminal differentiated cells (indicated by light coloured circles). Further 
differentiated precursor populations are therefore a heterogeneous mixture of primed cells (pool of 
cells in the rectangles in (B)), which share a – sometimes overlapping – common surface marker 





Figure. 3: Emergency monopoiesis and trained immunity. Compared to the physiological condition 
(left), severe inflammation can induce emergency monopoiesis leading to higher production of 
monocytes. Importantly, emergency monopoiesis also generates functionally distinct monocyte 
subsets with potentially alternative ancestry. These emergency-induced monocytes include neutrophil-
like Ly6CHi monocytes and SatM that display neutrophil characteristics, but also Sca1Hi monocytes 
with regulatory properties (middle). Emergency haematopoiesis can have long-lasting effects and 
yield in trained haematopoiesis characterized by a sustained increased production of monocytes that 
possess higher capacities to produce cytokines and superior microbicidal activities (right). The 
molecular mechanism that lead to the training effect and prevent haematopoiesis from returning to the 
steady-state after inflammation are starting to be revealed and involve IFN- and IL-1β-mediated 




Figure 4: Diversity of monocyte functions during physiological and pathological conditions. 
Monocytes can engraft into peripheral monocyte reservoirs or can differentiate into non-classical 
patrolling monocytes or tissue-resident macrophages in the steady-state. Monocytes can also acquire 
inflammatory, regenerative or antigen-presentation capacities when entering inflamed tissues. Severe 
inflammation can also lead to emergency monopoiesis with the production of novel subsets of 
monocytes with altered functional characteristics. Inflammation can have long-term effects on 
haematopoiesis and result in trained immunity associated with increased output of monocytes 
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